We are live on
!
Find out more
BA
BlackRock Advisors Portfolio holdings
AUM
$98.8B
1-Year Est. Return
15.8%
This Fund
S&P 500
This Quarter
Est. Return
-7.26%
1 Year Est. Return
+15.8%
3 Year Est. Return
+32.35%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$93.3B
AUM Growth
-$2.89B
(-3%)
Cap. Flow
+$5.74B
Cap. Flow
% of AUM
6.15%
Top 10 Holdings %
Top 10 Hldgs %
15.28%
Holding
3,878
New
163
Increased
1,568
Reduced
1,679
Closed
111
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$423M |
| 2 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$367M |
| 3 |
ExxonMobil
XOM
|
+$337M |
| 4 |
Johnson & Johnson
JNJ
|
+$257M |
| 5 |
Biogen
BIIB
|
+$250M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vertex Pharmaceuticals
VRTX
|
+$195M |
| 2 |
AbbVie
ABBV
|
+$188M |
| 3 |
JPMorgan Chase
JPM
|
+$183M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$176M |
| 5 |
Teva Pharmaceuticals
TEVA
|
+$174M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 18.49% |
| 2 | Financials | 16.75% |
| 3 | Technology | 9.99% |
| 4 | Industrials | 8.32% |
| 5 | Energy | 7.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
RT
2576
DELISTED
Ruby Tuesday Georgia
RT
| $252K | ﹤0.01% |
40,605
-1,325
| -3% | -$8.75K |
|
2577
FormFactor
FORM
$6.88B
| $251K | ﹤0.01% |
36,956
-7,123
| -16% | -$49.8K |
|
|
STRP
2578
DELISTED
Straight Path Communications Inc.
STRP
| $250K | ﹤0.01% |
6,189
-783
| -11% | -$22.6K |
|
2579
Anterix
ATEX
$1.78B
| $248K | ﹤0.01% |
8,289
+267
| +3% | +$8.74K |
|
|
RSO
2580
DELISTED
Resource Capital Corp.
RSO
| $248K | ﹤0.01% |
22,223
-1,324
| -6% | -$17.9K |
|
2581
Coeur Mining
CDE
$15.4B
| $247K | ﹤0.01% |
87,648
-1,659
| -2% | -$6.03K |
|
2582
Modine Manufacturing
MOD
$11B
| $246K | ﹤0.01% |
31,214
-619
| -2% | -$5.77K |
|
2583
Marten Transport
MRTN
$1.25B
| $246K | ﹤0.01% |
38,005
-218
| -0.6% | -$1.66K |
|
|
CSBK
2584
DELISTED
Clifton Bancorp Inc.
CSBK
| $246K | ﹤0.01% |
17,690
+867
| +5% | +$12.1K |
|
2585
Rockwell Medical
RMTI
$27.6M
| $245K | ﹤0.01% |
289
-2
| -0.7% | -$2.9K |
|
|
BHR
2586
Braemar Hotels & Resorts
BHR
$160M
| $244K | ﹤0.01% |
17,549
+1,697
| +11% | +$24.2K |
|
2587
StoneX
SNEX
$8.99B
| $244K | ﹤0.01% |
50,104
-450
| -0.9% | -$2.52K |
|
|
OME
2588
DELISTED
Omega Protein
OME
| $243K | ﹤0.01% |
14,345
-92,671
| -87% | -$1.44M |
|
2589
Univest Financial
UVSP
$1.24B
| $242K | ﹤0.01% |
12,577
+874
| +7% | +$17.2K |
|
|
TGH
2590
DELISTED
Textainer Group Holdings limited
TGH
| $242K | ﹤0.01% |
14,650
-244
| -2% | -$4.83K |
|
|
BTU
2591
DELISTED
PEABODY ENERGY CORP COM STK NEW (DE)
BTU
| $242K | ﹤0.01% |
11,710
-366
| -3% | -$8.26K |
|
2592
NMI Holdings
NMIH
$3.34B
| $241K | ﹤0.01% |
31,697
+6,907
| +28% | +$56.6K |
|
2593
First Financial Corp
THFF
$950M
| $241K | ﹤0.01% |
7,435
+302
| +4% | +$10.1K |
|
2594
Par Pacific Holdings
PARR
$3.97B
| $240K | ﹤0.01% |
11,500
-35,436
| -75% | -$682K |
|
2595
TTM Technologies
TTMI
$11.3B
| $240K | ﹤0.01% |
38,529
-890
| -2% | -$7K |
|
|
METR
2596
DELISTED
METRO BANCORP, INC COMMON STOCK
METR
| $240K | ﹤0.01% |
8,161
-376
| -4% | -$10.5K |
|
2597
Carriage Services
CSV
$648M
| $239K | ﹤0.01% |
11,056
-384
| -3% | -$8.8K |
|
2598
Financial Institutions
FISI
$830M
| $238K | ﹤0.01% |
9,601
-142
| -1% | -$3.48K |
|
2599
Marcus Corp
MCS
$766M
| $238K | ﹤0.01% |
12,329
-615
| -5% | -$12K |
|
|
ASCMA
2600
DELISTED
Ascent Capital Group, Inc. Series A
ASCMA
| $238K | ﹤0.01% |
8,701
-30,289
| -78% | -$1.01M |
|
Similar funds
BIM
BJ
IC
EAM
MFS
CIM
KAM
PFM
BlackRock Advisors's Q3 2015 Portfolio in Review
As of Q3 2015, BlackRock Advisors held 3,878 positions worth $93.3B, down 3% from $96.2B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
BlackRock Advisors deployed $5.74B of net new capital in Q3 2015, opening 163 new positions and adding to 1,568 existing holdings. Its largest new stake was Allergan plc: 186,940 shares worth $176M.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, down from 20% a quarter earlier, followed by Financials and Technology.
On the sell side, the largest reduction was Vertex Pharmaceuticals, an estimated $195M trimmed.
- BlackRock Advisors's largest Q3 2015 buy was Allergan plc: 186,940 shares worth $176M.
- BlackRock Advisors added most to Apple in Q3 2015, an estimated $423M increase.
- BlackRock Advisors's biggest Q3 2015 reduction was Vertex Pharmaceuticals, cutting an estimated $195M.
- BlackRock Advisors fully exited RECEPTOS INC COM STK (DE) in Q3 2015, selling an estimated $108M.
- BlackRock Advisors's ten largest holdings make up 15% of its $93.3B portfolio in Q3 2015.
- BlackRock Advisors opened 163 new positions and closed 111 in Q3 2015.
- BlackRock Advisors's portfolio value fell 3% quarter-over-quarter to $93.3B.
Based on BlackRock Advisors's 13F filing for Q3 2015, filed 13 Nov 2015.